RepliCel Life Sciences Inc. (TSXV:RP)
Canada
· Delayed Price · Currency is CAD 0.0150
+0.0050 (50.00%)
Inactive · Last trade price
on Feb 28, 2025
RepliCel Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 0.01 | 0.06 | 0.41 | 0.22 | 0.03 | 0.02 | Upgrade
|
| Short-Term Investments | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 0.01 | 0.08 | 0.43 | 0.24 | 0.05 | 0.05 | Upgrade
|
| Cash Growth | -67.78% | -82.24% | 80.46% | 361.97% | -2.02% | -97.82% | Upgrade
|
| Accounts Receivable | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Other Receivables | 0.01 | 0 | 0.05 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Receivables | 0.04 | 0.04 | 0.08 | 0.06 | 0.06 | 0.05 | Upgrade
|
| Prepaid Expenses | 0 | 0.05 | 0.12 | 0.09 | 0.07 | 0.13 | Upgrade
|
| Total Current Assets | 0.05 | 0.16 | 0.64 | 0.39 | 0.19 | 0.23 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Long-Term Accounts Receivable | 0.1 | 0.12 | 0.16 | 0.2 | 0.23 | 0.27 | Upgrade
|
| Total Assets | 0.15 | 0.29 | 0.8 | 0.59 | 0.42 | 0.51 | Upgrade
|
| Accounts Payable | 0.43 | 0.15 | 0.41 | 0.6 | 1.06 | 0.64 | Upgrade
|
| Accrued Expenses | 0.27 | 0.51 | 0.62 | 0.11 | 0.26 | 0.11 | Upgrade
|
| Short-Term Debt | 1.25 | 0.81 | 0.69 | 0.61 | 0.57 | 0.45 | Upgrade
|
| Current Unearned Revenue | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | Upgrade
|
| Total Current Liabilities | 2.3 | 1.82 | 2.07 | 1.67 | 2.24 | 1.55 | Upgrade
|
| Long-Term Debt | 0.06 | 0.06 | 0.04 | 0.03 | 0.03 | - | Upgrade
|
| Long-Term Unearned Revenue | 0.98 | 1.25 | 1.61 | 1.96 | 2.32 | 2.66 | Upgrade
|
| Other Long-Term Liabilities | 2 | 1.69 | 2.99 | 3.76 | 0.89 | 0.72 | Upgrade
|
| Total Liabilities | 5.34 | 4.82 | 6.71 | 7.43 | 5.48 | 4.93 | Upgrade
|
| Common Stock | 33.12 | 33.12 | 31.66 | 30.29 | 28.47 | 27.53 | Upgrade
|
| Additional Paid-In Capital | 5.64 | 5.64 | 5.4 | 5.1 | 4.63 | 4.62 | Upgrade
|
| Retained Earnings | -43.95 | -43.29 | -42.97 | -42.23 | -38.16 | -36.58 | Upgrade
|
| Shareholders' Equity | -5.19 | -4.53 | -5.92 | -6.84 | -5.06 | -4.43 | Upgrade
|
| Total Liabilities & Equity | 0.15 | 0.29 | 0.8 | 0.59 | 0.42 | 0.51 | Upgrade
|
| Total Debt | 1.31 | 0.87 | 0.73 | 0.65 | 0.59 | 0.45 | Upgrade
|
| Net Cash (Debt) | -1.3 | -0.8 | -0.3 | -0.41 | -0.54 | -0.4 | Upgrade
|
| Net Cash Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Filing Date Shares Outstanding | 65 | 65 | 65 | 42.75 | 36.04 | 31.94 | Upgrade
|
| Total Common Shares Outstanding | 65 | 65 | 47.6 | 34.96 | 29.95 | 24.72 | Upgrade
|
| Working Capital | -2.25 | -1.66 | -1.44 | -1.28 | -2.05 | -1.32 | Upgrade
|
| Book Value Per Share | -0.08 | -0.07 | -0.12 | -0.20 | -0.17 | -0.18 | Upgrade
|
| Tangible Book Value | -5.19 | -4.53 | -5.92 | -6.84 | -5.06 | -4.43 | Upgrade
|
| Tangible Book Value Per Share | -0.08 | -0.07 | -0.12 | -0.20 | -0.17 | -0.18 | Upgrade
|
| Machinery | - | - | - | 0.06 | 0.06 | 0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.